Literature DB >> 19574520

Integrating statistical and clinical research elements in intervention-related grant applications: summary from an NIMH workshop.

Joel T Sherrill1, David I Sommers, Andrew A Nierenberg, Andrew C Leon, Stephan Arndt, Karen Bandeen-Roche, Joel Greenhouse, Donald Guthrie, Sharon-Lise Normand, Katharine A Phillips, M Katherine Shear, Robert Woolson.   

Abstract

OBJECTIVE: The authors summarize points for consideration generated in a National Institute of Mental Health (NIMH) workshop convened to provide an opportunity for reviewers from different disciplines-specifically clinical researchers and statisticians-to discuss how their differing and complementary expertise can be well integrated in the review of intervention-related grant applications.
METHODS: A 1-day workshop was convened in October, 2004. The workshop featured panel presentations on key topics followed by interactive discussion. This article summarizes the workshop and subsequent discussions, which centered on topics including weighting the statistics/data analysis elements of an application in the assessment of the application's overall merit; the level of statistical sophistication appropriate to different stages of research and for different funding mechanisms; some key considerations in the design and analysis portions of applications; appropriate statistical methods for addressing essential questions posed by an application; and the role of the statistician in the application's development, study conduct, and interpretation and dissemination of results.
RESULTS: A number of key elements crucial to the construction and review of grant applications were identified. It was acknowledged that intervention-related studies unavoidably involve trade-offs. Reviewers are helped when applications acknowledge such trade-offs and provide good rationale for their choices. Clear linkage among the design, aims, hypotheses, and data analysis plan and avoidance of disconnections among these elements also strengthens applications.
CONCLUSION: The authors identify multiple points to consider when constructing intervention-related grant applications. The points are presented here as questions and do not reflect institute policy or comprise a list of best practices, but rather represent points for consideration.

Entities:  

Mesh:

Year:  2009        PMID: 19574520      PMCID: PMC2838497          DOI: 10.1176/appi.ap.33.3.221

Source DB:  PubMed          Journal:  Acad Psychiatry        ISSN: 1042-9670


  16 in total

1.  Toward rapproachment in the placebo control debate. A calculated compromise of power.

Authors:  Andrew C Leon; David A Solomon
Journal:  Eval Health Prof       Date:  2003-12       Impact factor: 2.651

2.  Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.

Authors:  Andrew C Leon
Journal:  J Clin Psychiatry       Date:  2004-11       Impact factor: 4.384

Review 3.  Size of treatment effects and their importance to clinical research and practice.

Authors:  Helena Chmura Kraemer; David J Kupfer
Journal:  Biol Psychiatry       Date:  2005-12-20       Impact factor: 13.382

Review 4.  Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology.

Authors:  Andrew C Leon; Craig H Mallinckrodt; Christy Chuang-Stein; Donald G Archibald; Graeme E Archer; Kevin Chartier
Journal:  Biol Psychiatry       Date:  2006-02-28       Impact factor: 13.382

Review 5.  Biostatistical collaboration in medical research.

Authors:  J H Ellenberg
Journal:  Biometrics       Date:  1990-03       Impact factor: 2.571

6.  Hazards of inference: the active control investigation.

Authors:  P D Leber
Journal:  Epilepsia       Date:  1989       Impact factor: 5.864

7.  False hopes and best data: consent to research and the therapeutic misconception.

Authors:  P S Appelbaum; L H Roth; C W Lidz; P Benson; W Winslade
Journal:  Hastings Cent Rep       Date:  1987-04       Impact factor: 2.683

8.  The number needed to treat: a clinically useful measure of treatment effect.

Authors:  R J Cook; D L Sackett
Journal:  BMJ       Date:  1995-02-18

9.  Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.

Authors:  R Temple; S S Ellenberg
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

10.  The continuing unethical conduct of underpowered clinical trials.

Authors:  Scott D Halpern; Jason H T Karlawish; Jesse A Berlin
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  4 in total

1.  The Career Development Institute for Psychiatry: an innovative, longitudinal program for physician-scientists.

Authors:  David J Kupfer; Alan F Schatzberg; Victoria J Grochocinski; Leslie O Dunn; Katherine A Kelley; Ruth M O'Hara
Journal:  Acad Psychiatry       Date:  2009 Jul-Aug

Review 2.  Cognitive training in mental disorders: update and future directions.

Authors:  Matcheri S Keshavan; Sophia Vinogradov; Judith Rumsey; Joel Sherrill; Ann Wagner
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

Review 3.  Factors influencing the statistical planning, design, conduct, analysis and reporting of trials in health care: A systematic review.

Authors:  Marina Zaki; Lydia O'Sullivan; Declan Devane; Ricardo Segurado; Eilish McAuliffe
Journal:  Contemp Clin Trials Commun       Date:  2022-01-29

4.  The effect of nocturnal wear of complete dentures on sleep and oral health related quality of life: study protocol for a randomized controlled trial.

Authors:  Elham Emami; Phan The Huy Nguyen; Fernanda R Almeida; Jocelyne S Feine; Igor Karp; Gilles Lavigne; Nelly Huynh
Journal:  Trials       Date:  2014-09-13       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.